DexCom Inc (DXCM)
138.70
-0.78
(-0.56%)
USD |
NASDAQ |
Mar 28, 16:00
138.54
-0.16
(-0.12%)
After-Hours: 20:00
DexCom Cash from Financing (Quarterly): -631.90M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -631.90M |
September 30, 2023 | -637.40M |
June 30, 2023 | 939.50M |
March 31, 2023 | 11.20M |
December 31, 2022 | -1.00M |
September 30, 2022 | -552.50M |
June 30, 2022 | -4.30M |
March 31, 2022 | 5.30M |
December 31, 2021 | -0.80M |
September 30, 2021 | 10.80M |
June 30, 2021 | -0.40M |
March 31, 2021 | 0.80M |
December 31, 2020 | -4.90M |
September 30, 2020 | 4.50M |
June 30, 2020 | 906.00M |
March 31, 2020 | 6.50M |
December 31, 2019 | -0.10M |
September 30, 2019 | 6.00M |
June 30, 2019 | -0.10M |
March 31, 2019 | 4.90M |
December 31, 2018 | 701.60M |
September 30, 2018 | 5.40M |
June 30, 2018 | -0.80M |
March 31, 2018 | 4.20M |
December 31, 2017 | 0.10M |
Date | Value |
---|---|
September 30, 2017 | 4.30M |
June 30, 2017 | 314.40M |
March 31, 2017 | 80.30M |
December 31, 2016 | 0.50M |
September 30, 2016 | 5.10M |
June 30, 2016 | -0.70M |
March 31, 2016 | 3.20M |
December 31, 2015 | 2.20M |
September 30, 2015 | 5.40M |
June 30, 2015 | 4.30M |
March 31, 2015 | 4.90M |
December 31, 2014 | 4.90M |
September 30, 2014 | 6.10M |
June 30, 2014 | 1.60M |
March 31, 2014 | 9.20M |
December 31, 2013 | 4.90M |
September 30, 2013 | 1.90M |
June 30, 2013 | 2.30M |
March 31, 2013 | 2.70M |
December 31, 2012 | 7.30M |
September 30, 2012 | 1.30M |
June 30, 2012 | 0.50M |
March 31, 2012 | 1.10M |
December 31, 2011 | 0.063M |
September 30, 2011 | 0.958M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-637.40M
Minimum
Sep 2023
939.50M
Maximum
Jun 2023
3.105M
Average
0.35M
Median
Cash from Financing (Quarterly) Benchmarks
Abbott Laboratories | -2.052B |
Integer Holdings Corp | 17.52M |
Intuitive Surgical Inc | -31.50M |
Edwards Lifesciences Corp | -413.20M |
Insulet Corp | 2.20M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 133.60M |
Cash from Investing (Quarterly) | 414.90M |
Free Cash Flow | 511.90M |
Free Cash Flow Per Share (Quarterly) | 0.1944 |
Free Cash Flow to Equity (Quarterly) | 203.50M |
Free Cash Flow to Firm (Quarterly) | 81.10M |
Free Cash Flow Yield | 0.87% |